Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
>Potential legit reasons for CVSI shares getting crushed (and overdone ) :
Northland remained a Buy rating on CVSI but lowered their target from $8 to $6
In March it was $8 link - > https://www.analystratings.com/articles/northland-securities-sticks-to-its-buy-rating-for-cv-sciences-inc-cvsi/
Now in August it is $6 link - > https://www.smarteranalyst.com/new-blurbs/analysts-offer-insights-on-services-companies-cv-sciences-inc-othercvsi-vonage-holdings-vg-and-sailpoint-technologies-holdings-inc-sail/
Refresh my memory did the FD shares go up for the Mona package before the Q1 report or after? The lowered target could also partially reflect increased FD shares if so. Wasn't it 15-20m shares? I don't recall and too tired to look up right now.
So the lowered price target could have caused panic , and longs could have thrown in the towel and shorts may have gotten very aggressive. But please let's stop the fanatical short conspiracy theories beyond that or OTCBB issues. A better question why does Northland now think $6 or $720 million dollar market cap is fair value ( FD 120m shares ) ? CW analysts all have targets of approximately $2 billion market cap or more and CW does approximately 50% more in sales than CV.
However #2 is this Adjusted EBITDA for the second quarter of 2019 was $3.6 million or 21.1% of net revenue, compared to $3.8 million or 31.1% of net revenue, in the second quarter of 2018. CW does 30-35% adjusted EBITDA %. CV dipped to 21% this quarter. Albeit I agree with many investment in R&D as well as sales and marketing at this stage of the product cycle should be viewed as a positive investment. CV management should have done a MUCH better job addressing this on the call. Additionally they could have talked about plans to drive internet sales higher. I was not super impressed with the CEO or CFO as far as aggressive confidence in building out a global top CPG brand to be honest, meaning they could have been more aggressive and covered these important topics in more detail as well.
I think there is BIG value in the CV brand as the #2 in TOTAL sales. SPINS data is a solid/awesome data point but it doesn't make them #1 in total sales and they should be working to advance other sales channels higher.
I think big weed companies and even CPG companies are going to smell blood in the water and what better way to get an instant foothold in the top CBD market in the world than acquire the #2 brand in total sales and #1 in SPINS data?
Why do analysts think this is only worth $720 million ? Some of the above factors? I think personally a buyout would be an all stock deal for $700m - $1 billion. Why would CV take that ? Did you hear how many times they mentioned increased competition ? CW never mentions that or has seemed worried in the least about that. They need a bigger management team with either deeper pockets or massive CPG experience to take CV to the next level imo. Also, at some point if they are truly going to develop the anti - tobacco drug they WILL need cash. Honestly, I think they will need more cash just to grow out the CBD brand to compete globally with CW and others. So I think CV WOULD take an offer of $6-$10 if they were approached which is just my thesis. Another idea would be for CV to merge with ELLXF and get instant global footprint and 25% of Pet Releaf one of the top pet CBD brands.
In conclusion, the stock is WAY oversold imo and if there are shorts overstaying their welcome a big news release could cause a nice squeeze.
Potential legit reasons for CVSI shares getting crushed (and overdone ) :
Northland remained a Buy rating on CVSI but lowered their target from $8 to $6
In March it was $8 link - > https://www.analystratings.com/articles/northland-securities-sticks-to-its-buy-rating-for-cv-sciences-inc-cvsi/
Now in August it is $6 link - > https://www.smarteranalyst.com/new-blurbs/analysts-offer-insights-on-services-companies-cv-sciences-inc-othercvsi-vonage-holdings-vg-and-sailpoint-technologies-holdings-inc-sail/
Refresh my memory did the FD shares go up for the Mona package before the Q1 report or after? The lowered target could also partially reflect increased FD shares if so. Wasn't it 15-20m shares? I don't recall and too tired to look up right now.
So the lowered price target could have caused panic , and longs could have thrown in the towel and shorts may have gotten very aggressive. But please let's stop the fanatical short conspiracy theories beyond that or OTCBB issues. A better question why does Northland now think $6 or $720 million dollar market cap is fair value ( FD 120m shares ) ? CW analysts all have targets of approximately $2 billion market cap or more and CW does approximately 50% more in sales than CV.
However #2 is this Adjusted EBITDA for the second quarter of 2019 was $3.6 million or 21.1% of net revenue, compared to $3.8 million or 31.1% of net revenue, in the second quarter of 2018. CW does 30-35% adjusted EBITDA %. CV dipped to 21% this quarter. Albeit I agree with many investment in R&D as well as sales and marketing at this stage of the product cycle should be viewed as a positive investment. CV management should have done a MUCH better job addressing this on the call. Additionally they could have talked about plans to drive internet sales higher. I was not super impressed with the CEO or CFO as far as aggressive confidence in building out a global top CPG brand to be honest, meaning they could have been more aggressive and covered these important topics in more detail as well.
I think there is BIG value in the CV brand as the #2 in TOTAL sales. SPINS data is a solid/awesome data point but it doesn't make them #1 in total sales and they should be working to advance other sales channels higher.
I think big weed companies and even CPG companies are going to smell blood in the water and what better way to get an instant foothold in the top CBD market in the world than acquire the #2 brand in total sales and #1 in SPINS data?
Why do analysts think this is only worth $720 million ? Some of the above factors? I think personally a buyout would be an all stock deal for $700m - $1 billion. Why would CV take that ? Did you hear how many times they mentioned increased competition ? CW never mentions that or has seemed worried in the least about that. They need a bigger management team with either deeper pockets or massive CPG experience to take CV to the next level imo. Also, at some point if they are truly going to develop the anti - tobacco drug they WILL need cash. Honestly, I think they will need more cash just to grow out the CBD brand to compete globally with CW and others. So I think CV WOULD take an offer of $6-$10 if they were approached which is just my thesis. Another idea would be for CV to merge with ELLXF and get instant global footprint and 25% of Pet Releaf one of the top pet CBD brands.
In conclusion, the stock is WAY oversold imo and if there are shorts overstaying their welcome a big news release could cause a nice squeeze.
Receivables are recognized as sales in current period ( debit receivables and credit sales ) . However cash is collected at later date (debit cash and credit receivables). . Not sure if you meant wasn’t recognized as sales or cash
Meant 120 vs 112 not 98 . Six month FD was 98
Fully diluted 120m what was it prior periods ? And yes I know damn well the difference geeez
50 I just work hard at keeping young !
Yeah his questions are weak on the calls also like he doesn’t get the business
Could it be because of dilution ? $8 x 95 O/S = $760m and $6 x 120m O/S = $720m
was his target originally at $8 and he took it down to $6 ?
what is this " Northlands 25% CVSI SP stock adj published a bit earlier "
One does not have cbd in name or label ?
PlusHemp Extract? I always wondered if this is why CW does not mention CBD anywhere on the label. Not sure if your thesis is correct though ? That is not why they went after CUraleaf
so worse case CV has to rebrand ? where are you getting this from
imo the brand has value and someone will swoop in at these prices $6-$8 offer or something. just my thesis.
wouldnt that go for all CBD on market ?
Congress on recess until mid September I believe
Congress on recess until mid September I believe
interactive brokers has a column so you can see how many shorts they have available to short for a given symbol . several brokers do this some you have to call . common knowledge
geez this is ridiculous . company will get taken over imo. $6-$10 low to high range my guess
Why would people be selling and/or shorting at $3.35 in volume ? That is the question I would like answered. There were still 2m shorts in the low $4's as of the last report. I would like to know why people think this is . I am looking to add more
you entered at .44 and held all the way up to the $9's and did not sell ?
put the pom poms away, CVSI cant hold gains again. Why would people be selling and/or shorting at $3.35 in volume ? That is the question I would like answered. There were still 2m shorts in the low $4's as of the last report. I would like to know why people think this is
hahah I do know what it is . Do you know how to read a 10-Q ?
Interactive Brokers just ran out of CVSI shorts available to short. It was 20k to start the day and has been in several hundred thousand available past week.
I do not see how it applies to yesterday. There were no negative rumors about CVSI , nor did a big name or anyone really tweet negative about it.
CVSI slight gap this morning .
I meant CVSI needs to sell the company not sell the stock which I am long. and you seem the fragile one if anyone disagrees with you
CVSI potential near term catalysts. Will Piper initiate coverage? If the California bill passes does anyone have estimate how many stores CVSI will increase?
Read the post i responded to he insulted me left and right
Wolf, CVSI R&D is split between development of their nicotine drug and their CBD segment. Page 16 of the 10Q. So 600k on CBD R&D is something not much at all.
Research and development (“R&D”) expense increased to $1.7 million in the second quarter of 2019 compared to $0.4 million in the second quarter of 2018. The increase of $1.3 million or 282% is related to additional R&D expenses for our specialty pharmaceutical segment of $0.7 million and for our consumer products segment of $0.6 million. The increase in our specialty pharmaceutical segment is mostly related to preclinical work, development cost associated with our active pharmaceutical ingredient ("API"), and expenses paid to outside consultants. The additional R&D expense in our consumer products segment is mostly related to additional personnel cost, cost for clinical trials, and cost for outside services for our new consumer product developments.
II love all the wild fanatical conspiracy theories here
It was posted to the CV website. I was alerted from Interactive brokers that the release was out and couldn’t open it and i had the CV website open and was refreshing it
More insults on this board. Thats why I crushed CW from 9 to 25 why you were in here pontificating about self affirmed GRAS and industrial hemp and CV was flat for a year now tanked. I moved over and took position here in CV because as the alleged #2 brand there has to be some value here. So you may be good at frustrated angry posts but so far your timing for picking stocks is horrible. Who is smarter? I def make more than you do in stocks that’s for sure ha . Angry J
4m shares after the 300k you claim took down this stock was churn? What do you mean by churn ? Who do you think were the sellers of the 4m? I’m not saying i know just curious your theory
Did you confirm what it was last quarter (Q1) for CV ? I know the spider is around 50%
No CVSI doesn’t give guidance so far
I was upset for different reasons. But not trying to bring up the other company. Want to keep discussions to CVSI . Hope Piper initiates in the morning on CV
Exactly !!
Yes this price point impacts chance to uplist or no ? They have to sell imo